Sottotitolo del Comitato Scientifico
The cornerstone of our work is scientific and clinical research, professionally and passionately conducted over the last four years. This has culminated in our very approach, dedicated to discovering and explaining the correlation between the immune system as a potential cause of subfertility and unexplained infertility, with the support of in-depth scientific knowledge. To date we have helped over 220 women to identify potential causes of failed conception, or the recurrence of spontaneous abortions.
We read, analysed and assessed thousands of publications from the last decade, while also performing meticulous statistical analyses on works which not only have inspired, but also constituted a solid scientific basis for the rigorous and methodological development of our own research, based on science followed by the clinical validation of data.
Successively, we dedicated ourselves to researching new biomarkers and validating a new panel of tests which could be applied as a diagnostic method, to find scientifically demonstrable correlations between imbalances in some components of the immune system, and the state of subfertility or unexplained infertility. This is what constituted part of our scientific foundation.
The new diagnostic test
After approximately 1 year of study and research, we identified 4 highly promising biomarkers, linked to different areas of the immune system, each producing conception-hindering effects if present in quantities exceeding normal physiological values. We tested them for over 3 years and demonstrated the following in particular:
To date we have conducted three clinical studies (which will soon be published). The first was to validate the diagnostic method in a cohort of over 400 women. The second was to validate our supplement, involving a population of approximately 50 women, and the third was to validate our diagnostic method within a population of over 2200 women tested for all four biomarkers, where important correlations were discovered between the presence of biomarkers, age, duration of the state of subfertility or infertility, etc.
A new clinical study will begin towards the end of 2017 at Rome's Ospedale Gemelli, led by Prof. Giovanni Scambia, with the aim of validating our test for diagnosing and understanding the causes of recurring spontaneous abortions, and to validate our supplement which aims to counter any negative effects.
A new, natural programme towards pregnancy
Over 40% of analysed blood samples from women affected by subfertility or unexplained infertility test positive for at least one of the biomarkers, presenting with a higher value than the physiological one.
Consequently we have found the conception rate among the population of women who test positive to be less than 4%.
Therefore we developed and clinically tested a new botanic, 100% natural supplement, which proved to regularise the menstrual cycle, and above all, restore the organism's natural defences and reduce oxidation, returning single biomarker values to normal physiological reference values.